Literature DB >> 8601364

Gallstone recurrence after successful dissolution therapy.

J Tudyka1, J G Wechsler, W Kratzer, C Maier, R Mason, K Kuhn, G Adler.   

Abstract

After successful dissolution therapy of cholesterol gallbladder stones bile again becomes supersaturated and recurrent gallstones may develop. Three different postdissolution treatments [500 mg ursodeoxycholic acid (UDCA) per day (N = 14, group I), 100 mg aspirin per day (N = 14, group II) and diet (N = 15, group III) versus a control group (no treatment, N = 15, group IV) aimed at preventing recurrence of gallstones were investigated in a prospective, randomized study in 58 gallstone patients (33 female, 25 male) after complete stone clearance. Bile samples (prior to dissolution therapy and at stone recurrence) were investigated for biliary cholesterol (C), phospholipids (PL), total bile acid concentration (BA), cholesterol saturation index (CSI), total lipid concentration (TLC), total biliary protein concentration (TP), and nucleation time (NT). In group IV multiple gallstones tended to recur more often than solitary stones (66.7% vs 16.7%) whereas in groups I-III only solitary stones recurred. Recurrent gallbladder stones were detectable in 10 patients (eight patients in group IV and one each in groups I and II, respectively) within one year after dissolution and in two patients (one each in groups III and IV, respectively) after 15 months. Furthermore, the probability of stone recurrence was significantly higher in untreated patients as compared to treated patients. In nine (group IV) of 12 patients with recurrent stones NT, C, CSI, PL, BA, TLC, TP, and bile acid spectrum remained nearly unchanged as compared to their pretreatment values, whereas in three (groups I-III) of 12 cases a decrease in C, CSI, and TP was observed during therapy. However, in each of these three patients, initial and after-treatment TP was significantly higher and NT shorter as compared to groups I-IV. Furthermore, in these cases (N = 3) NT was prolonged, whereas no significant changes were found in PL, BA, TLC, and bile acid spectrum. Recurrence of gallstones, which seems to occur more likely in patients with multiple stones as compared to solitary stones, will happen in the early stage after stone clearance, again causing biliary pain. UDCA, aspirin or diet will reduce the probability for recurrent stones after complete gallstone dissolution.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601364     DOI: 10.1007/bf02093810

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Comparison of gall bladder bile and endoscopically obtained duodenal bile.

Authors:  P Janowitz; W Swobodnik; J G Wechsler; A Zöller; K Kuhn; H Ditschuneit
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

2.  Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter.

Authors:  J L Thistle; G R May; C E Bender; H J Williams; A J LeRoy; P E Nelson; C J Peine; B T Petersen; J E McCullough
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

3.  Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations.

Authors:  M J Allen; T J Borody; T F Bugliosi; G R May; N F LaRusso; J L Thistle
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

4.  Rapid and accurate reversed-phase high-performance liquid chromatographic determination of conjugated bile acids in human bile for routine clinical applications. Therapeutic control during gallstone dissolution therapy.

Authors:  W Swobodnik; U Klüppelberg; J G Wechsler; M Volz; G Normandin; H Ditschuneit
Journal:  J Chromatogr       Date:  1985-05-03

5.  [Wheat bran-type roughage reduces the lithogenicity of bile].

Authors:  J G Wechsler; W Swobodnik; H Wenzel; T Heuchemer; W Nebelung; V Hutt; H Ditschuneit
Journal:  Dtsch Med Wochenschr       Date:  1984-08-24       Impact factor: 0.628

6.  Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment.

Authors:  N Villanova; F Bazzoli; F Taroni; R Frabboni; G Mazzella; D Festi; L Barbara; E Roda
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

7.  Gallstone recurrence after medical dissolution. An overestimated threat?

Authors:  A Lanzini; R P Jazrawi; R M Kupfer; D P Maudgal; A E Joseph; T C Northfield
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

Review 8.  [Dietary modification of bile lipids].

Authors:  J G Wechsler; H Wenzel; W Swobodnik; S Splitt; P Janowitz; H Ditschuneit
Journal:  Leber Magen Darm       Date:  1988-02

9.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

10.  Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.

Authors:  T A Sylwestrowicz; E A Shaffer
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  1 in total

Review 1.  The pathogenesis of cholesterol gallstones a review.

Authors:  S M Strasberg
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.